EUVIMEDEUVIMED entdecken
Open Access

Development of Substituted Phenyl Dihydrouracil as the Novel Achiral Cereblon Ligands for Targeted Protein Degradation

Haibo Xie iD, Chunrong Li, Hua Tang, Ira Tandon, Junzhuo Liao, Brett L Roberts iD, Yu Zhao, Weiping Tang iD

Journal of Medicinal Chemistry · 23.02.2023 · 66 (4) · 2904-2917

DOI: 10.1021/acs.jmedchem.2c01941 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 07.02.2023. Verfasst von Haibo Xie und 7 weiteren Autor:innen. Beteiligte Einrichtung: Lachman Institute for Pharmaceutical Development, School of Pharmacy, University of Wisconsin-Madison, 777 Highland Avenue, Madison, Wisconsin 53705 …. Hauptthemen laut MEDLINE: Adaptor Proteins, Signal Transducing, Nuclear Proteins, Proteolysis, Ubiquitin-Protein Ligases. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, Wisconsin Alumni Research Foundation, Center for Scientific Review.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glutarimides such as thalidomide, pomalidomide, and lenalidomide are the most frequently used ligands to recruit E3 ubiquitin ligase cereblon (CRBN) for the development of proteolysis-targeting chimeras (PROTACs). Due to the rapid and spontaneous racemization of glutarimides, most CRBN-recruiting PROTACs are synthesized as a mixture of racemates or diastereomers. Since the (S)-enantiomer is primarily responsible for binding to CRBN, the existence of the largely inactive (R)-enantiomer complicates the drug development process. Herein, we report that substituted achiral phenyl dihydrouracil (PDHU) can be used as a novel class of CRBN ligands for the development of PROTACs. Although the parent PDHU has a minimal binding affinity to CRBN, we found that some substituted PDHUs had a comparable binding affinity to lenalidomide. Structural modeling provided a further understanding of the molecular interactions between PDHU ligands and CRBN. PDHUs also have greater stability than lenalidomide. Finally, potent BRD4 degraders were developed by employing trisubstituted PDHUs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adaptor Proteins, Signal TransducingNuclear ProteinsProteolysisUbiquitin-Protein LigasesLenalidomideLigandsTranscription FactorsUracil

Substanzen

Adaptor Proteins, Signal TransducingLenalidomideLigandsNuclear ProteinsTranscription FactorsUbiquitin-Protein LigasesdihydrouracilUracilCRBN protein, human

Autor:innen und Institutionen

  • Lachman Institute for Pharmaceutical Development, School of Pharmacy, University of Wisconsin-Madison, 777 Highland Avenue, Madison, Wisconsin 53705 United States.
  • Department of Chemistry, University of Wisconsin-Madison, 1101 University Avenue, Madison, Wisconsin 53706, United States.

ORCID-Profile: Haibo Xie, Brett L Roberts, Weiping Tang

Förderung

  • NIGMS NIH HHS
  • Wisconsin Alumni Research Foundation
  • Center for Scientific Review
  • University of Wisconsin-Madison

Zitieren

APA

Xie, H., Li, C., Tang, H., Tandon, I., Liao, J., Roberts, B. L., Zhao, Y., & Tang, W. (2023). Development of Substituted Phenyl Dihydrouracil as the Novel Achiral Cereblon Ligands for Targeted Protein Degradation. Journal of Medicinal Chemistry, 66(4), 2904-2917. https://doi.org/10.1021/acs.jmedchem.2c01941

Vancouver

Xie H, Li C, Tang H, Tandon I, Liao J, Roberts BL, et al. Development of Substituted Phenyl Dihydrouracil as the Novel Achiral Cereblon Ligands for Targeted Protein Degradation. Journal of Medicinal Chemistry. 2023;66(4):2904-2917. doi:10.1021/acs.jmedchem.2c01941

BibTeX
@article{Xie2023,
  author = {Xie, Haibo and Li, Chunrong and Tang, Hua and Tandon, Ira and Liao, Junzhuo and Roberts, Brett L and Zhao, Yu and Tang, Weiping},
  title = {Development of Substituted Phenyl Dihydrouracil as the Novel Achiral Cereblon Ligands for Targeted Protein Degradation},
  journal = {Journal of Medicinal Chemistry},
  year = {2023},
  volume = {66},
  number = {4},
  pages = {2904--2917},
  doi = {10.1021/acs.jmedchem.2c01941}
}
Kostenlos starten →